The finding from the Mueller lab paves the way for scientists to produce these neurons in culture—a first step in developing better treatments for cognitive disorders such as schizophrenia and autism.
Work from the Koob lab shows a fine-tuned combination of two existing pharmaceutical drugs made laboratory rats less likely to take cocaine compulsively.
The experimental drug, developed in part by Professor John Griffin’s lab, may extend the window for effective stroke treatment.
The NIH grant to Associate Professor Andrew Butler will fund a study on the pathways that regulate the timing of our desire for food throughout the day.